Comparative Adverse Event Reporting of Asparaginase-Containing Induction Regimens in Pediatric Acute Lymphoblastic Leukemia Using the United States Food and Drug Administration Adverse Event Reporting System

Toru Ogura, Chihiro Shiraishi

Open source

DOI
10.7759/cureus.108119
Published
2026-05-01
Container
Cureus
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.7759/cureus.108119,
  title = {Comparative Adverse Event Reporting of Asparaginase-Containing Induction Regimens in Pediatric Acute Lymphoblastic Leukemia Using the United States Food and Drug Administration Adverse Event Reporting System},
  author = {Toru Ogura and Chihiro Shiraishi},
  year = {2026},
  journal = {Cureus},
  doi = {10.7759/cureus.108119},
  url = {https://doi.org/10.7759/cureus.108119}
}

RIS

TY  - JOUR
TI  - Comparative Adverse Event Reporting of Asparaginase-Containing Induction Regimens in Pediatric Acute Lymphoblastic Leukemia Using the United States Food and Drug Administration Adverse Event Reporting System
AU  - Toru Ogura
AU  - Chihiro Shiraishi
PY  - 2026
JO  - Cureus
DO  - 10.7759/cureus.108119
UR  - https://doi.org/10.7759/cureus.108119
ER  - 

APA

Ogura, T., & Shiraishi, C. (2026). Comparative Adverse Event Reporting of Asparaginase-Containing Induction Regimens in Pediatric Acute Lymphoblastic Leukemia Using the United States Food and Drug Administration Adverse Event Reporting System. Cureus. https://doi.org/10.7759/cureus.108119

Source records